Adial Pharmaceuticals, Inc. Increase (Decrease) in Due from Related Parties
Adial Pharmaceuticals, Inc. (ADIL) reported Increase (Decrease) in Due from Related Parties of $48.27 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueFromRelatedParties · last filed 2026-08-14
- Adial Pharmaceuticals, Inc. increase (decrease) in due from related parties for the quarter ending 2025-12-31 was $0.00.
- Adial Pharmaceuticals, Inc. increase (decrease) in due from related parties for the quarter ending 2025-09-30 was $272.00.
- Adial Pharmaceuticals, Inc. increase (decrease) in due from related parties for the quarter ending 2025-06-30 was $33.06K.
- Adial Pharmaceuticals, Inc. increase (decrease) in due from related parties for the quarter ending 2025-03-31 was $14.94K, a 37.92% decline year-over-year.
- Adial Pharmaceuticals, Inc. increase (decrease) in due from related parties for fiscal 2025 was $48.27K.
- Adial Pharmaceuticals, Inc. increase (decrease) in due from related parties for fiscal 2024 was -$24.21K.
| Period end | Increase (Decrease) in Due from Related Parties 3 month | Increase (Decrease) in Due from Related Parties 6 month | Increase (Decrease) in Due from Related Parties 6 month as first filed | Increase (Decrease) in Due from Related Parties 9 month | Increase (Decrease) in Due from Related Parties 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $272.00 derived: sum of 2 quarters · filed 2026-03-05 | $33.34K derived: sum of 3 quarters · filed 2026-08-14 | $48.27K 10-K · filed 2026-03-05 | |
| 2025-09-30 | $272.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $33.34K derived: sum of 2 quarters · filed 2026-08-14 | $48.27K 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $33.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $48.00K 10-Q · filed 2026-08-14 | $48.27K 10-Q · filed 2025-08-13 | -$272.00 derived: sum of 3 quarters · filed 2026-08-14 | -$272.00 derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $14.94K 10-Q · filed 2026-05-08 | -$33.34K derived: sum of 2 quarters · filed 2026-05-08 | -$33.34K derived: sum of 3 quarters · filed 2026-05-08 | -$33.34K derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$48.27K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$48.27K derived: sum of 2 quarters · filed 2026-03-05 | -$48.27K derived: sum of 3 quarters · filed 2026-03-05 | -$24.21K 10-K · filed 2026-03-05 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $24.06K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $24.06K 10-Q · filed 2025-08-13 | |||
| 2024-03-31 | $24.06K 10-Q · filed 2025-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |